Effects of a NeuroAD System, for the Treatment of Alzheimer Disease

Clinical trial NCT02166827 · TERMINATED

Trial details

NCT number: NCT02166827
Sponsor: Neuronix Ltd
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2014-11-01
Primary completion: 2015-11-01
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.